EU Drug Filings To Fall Slightly In 2019, But Scientific Advice On The Up
Executive Summary
The EMA expects initial applications for drug approvals to decline slightly next year, with the budget also down a little because of Brexit uncertainty. The agency's management board reported on its visit to the agency’s future home in Amsterdam.